Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy

Roberto Fogari; A. Zoppi; A. Mugellini; P. Preti; M. Destro; A. Rinaldi; G. Derosa

doi:10.1007/BF02850307

Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy

Roberto Fogari, A. Zoppi, A. Mugellini, P. Preti, M. Destro, A. Rinaldi, G. Derosa

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Abstract

This study was undertaken to evaluate the effects on blood pressure of hydrochlorothiazide (HCTZ) 12.5 mg added to valsartan 160 mg or to olmesartan 20 mg in hypertensive patients. After a 2-wk placebo period, 130 patients, aged 35 to 75 y, with diastolic blood pressure (DBP) ≥99 and

Original language	English
Pages (from-to)	680-695
Number of pages	16
Journal	Advances in Therapy
Volume	23
Issue number	5
DOIs	https://doi.org/10.1007/BF02850307
Publication status	Published - Sep 2006

Keywords

Hydrochlorothiazide
Hypertension
Olmesartan
Valsartan

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/BF02850307

Cite this

Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy. / Fogari, Roberto; Zoppi, A.; Mugellini, A. et al.

In: Advances in Therapy, Vol. 23, No. 5, 09.2006, p. 680-695.

Research output: Contribution to journal › Article › peer-review

@article{08052e4b138242d3bbe7773b010df5cc,

title = "Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy",

abstract = "This study was undertaken to evaluate the effects on blood pressure of hydrochlorothiazide (HCTZ) 12.5 mg added to valsartan 160 mg or to olmesartan 20 mg in hypertensive patients. After a 2-wk placebo period, 130 patients, aged 35 to 75 y, with diastolic blood pressure (DBP) ≥99 and ",

keywords = "Hydrochlorothiazide, Hypertension, Olmesartan, Valsartan",

author = "Roberto Fogari and A. Zoppi and A. Mugellini and P. Preti and M. Destro and A. Rinaldi and G. Derosa",

year = "2006",

month = sep,

doi = "10.1007/BF02850307",

language = "English",

volume = "23",

pages = "680--695",

journal = "Advances in Therapy",

issn = "0741-238X",

publisher = "Springer Healthcare",

number = "5",

}

TY - JOUR

T1 - Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy

AU - Fogari, Roberto

AU - Zoppi, A.

AU - Mugellini, A.

AU - Preti, P.

AU - Destro, M.

AU - Rinaldi, A.

AU - Derosa, G.

PY - 2006/9

Y1 - 2006/9

N2 - This study was undertaken to evaluate the effects on blood pressure of hydrochlorothiazide (HCTZ) 12.5 mg added to valsartan 160 mg or to olmesartan 20 mg in hypertensive patients. After a 2-wk placebo period, 130 patients, aged 35 to 75 y, with diastolic blood pressure (DBP) ≥99 and

AB - This study was undertaken to evaluate the effects on blood pressure of hydrochlorothiazide (HCTZ) 12.5 mg added to valsartan 160 mg or to olmesartan 20 mg in hypertensive patients. After a 2-wk placebo period, 130 patients, aged 35 to 75 y, with diastolic blood pressure (DBP) ≥99 and

KW - Hydrochlorothiazide

KW - Hypertension

KW - Olmesartan

KW - Valsartan

UR - http://www.scopus.com/inward/record.url?scp=33845602177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845602177&partnerID=8YFLogxK

U2 - 10.1007/BF02850307

DO - 10.1007/BF02850307

M3 - Article

C2 - 17142202

AN - SCOPUS:33845602177

VL - 23

SP - 680

EP - 695

JO - Advances in Therapy

JF - Advances in Therapy

SN - 0741-238X

IS - 5

ER -

Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this